Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Contractor for clinician-focused addiction recovery program sued over ‘punishingly expensive’ practices
The plaintiffs, 10 nurses and one doctor, are all enrolled in the state-mandated initiative for clinicians with past substance abuse issues. The rules require monitoring and regular drug testing to prove sobriety; however, the lot argues that the contractor in charge, Maximus, is being dishonestly punitive.
COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination
Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.
How to minimize bleeding risks after TAVR
Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.
Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly
Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.

Healthcare consumers are coming up to speed on IR, albeit too slowly for some insiders

In the years since the turn of the century, interventional radiology has made quantifiable strides toward familiarizing the general public with the specialty and, along the way, helping IR better compete for business with surgery.

A busy week for cardiology investments: 3 tech companies report big financing rounds

It’s not even Valentine’s Day yet, but February has already been a big month for fundraising in the cardiology space.

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

Cardiologists ask popular AI model ChatGPT to answer questions about cardiology

Can ChatGPT discuss preventive cardiology with patients? Cardiologists with Cleveland Clinic and Stanford University put the popular AI model to the test, sharing their findings in JAMA.

Appearances can be deceiving on chest CT performed for COVID in cancer patients

In a study of more than 250 COVID-positive patients with a history of any cancer, fewer than half the cohort had chest CT findings deemed typical for COVID-related pneumonia based on an RSNA classification guide.

Image courtesy of the University of Missouri Zheng Yan, PhD

Researchers design new material for wearable devices: ‘You cannot feel it, and you will likely forget about it’

The soft, stretchable material creates so little pressure that users will likely not even even be able to feel it.

New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more

The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a "critical roadmap" for clinicians.

Healthcare workforce management company raises $200M

The funding comes at a time when the healthcare workforce is facing a major labor crunch.

Clinical

Contractor for clinician-focused addiction recovery program sued over ‘punishingly expensive’ practices

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination

How to minimize bleeding risks after TAVR

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Private equity-backed Medline files for IPO